Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

The ovarian cycle may influence the exhaled volatile organic compound profile analyzed by an electronic nose.

Dragonieri S, Quaranta VN, Carratu P, Ranieri T, Resta O.

J Breath Res. 2018 Mar 1;12(2):021002. doi: 10.1088/1752-7163/aa9eed.

PMID:
29199639
2.

Influence of circadian rhythm on exhaled breath profiling by electronic nose.

Liotino V, Dragonieri S, Quaranta VN, Carratu P, Ranieri T, Resta O.

J Biol Regul Homeost Agents. 2018 Sep-Oct;32(5):1261-1265.

PMID:
30334423
3.

Lack of heritability of exhaled volatile compound pattern: an electronic nose twin study.

Tarnoki DL, Bikov A, Tarnoki AD, Lazar Z, Szilagyi BK, Korosi BZ, Horvath T, Littvay L, Losonczy G, Horvath I.

J Breath Res. 2014 Mar;8(1):016001. doi: 10.1088/1752-7155/8/1/016001. Epub 2014 Jan 13.

PMID:
24421262
4.

Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose.

Dragonieri S, Quaranta VN, Carratu P, Ranieri T, Resta O.

J Bras Pneumol. 2016 Apr;42(2):143-5. doi: 10.1590/S1806-37562015000000195. English, Portuguese.

5.

Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose.

Kunos L, Bikov A, Lazar Z, Korosi BZ, Benedek P, Losonczy G, Horvath I.

Sleep Breath. 2015 Mar;19(1):247-53. doi: 10.1007/s11325-014-1003-z. Epub 2014 May 20.

PMID:
24840212
6.

Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study.

Dragonieri S, Quaranta VN, Carratu P, Ranieri T, Resta O.

J Breath Res. 2016 Nov 3;10(4):041001.

PMID:
27811380
7.

Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer.

Bikov A, Hernadi M, Korosi BZ, Kunos L, Zsamboki G, Sutto Z, Tarnoki AD, Tarnoki DL, Losonczy G, Horvath I.

BMC Pulm Med. 2014 Dec 16;14:202. doi: 10.1186/1471-2466-14-202.

8.

An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.

Dragonieri S, Annema JT, Schot R, van der Schee MP, Spanevello A, Carratú P, Resta O, Rabe KF, Sterk PJ.

Lung Cancer. 2009 May;64(2):166-70. doi: 10.1016/j.lungcan.2008.08.008. Epub 2008 Oct 1.

PMID:
18834643
9.

Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose.

Hattesohl AD, Jörres RA, Dressel H, Schmid S, Vogelmeier C, Greulich T, Noeske S, Bals R, Koczulla AR.

Respirology. 2011 Nov;16(8):1258-64. doi: 10.1111/j.1440-1843.2011.02047.x.

PMID:
21883674
10.

An electronic nose in the discrimination of obese patients with and without obstructive sleep apnoea.

Dragonieri S, Porcelli F, Longobardi F, Carratù P, Aliani M, Ventura VA, Tutino M, Quaranta VN, Resta O, de Gennaro G.

J Breath Res. 2015 Apr 20;9(2):026005. doi: 10.1088/1752-7155/9/2/026005.

PMID:
25891965
11.

Inflammatory markers: exhaled nitric oxide and carbon monoxide during the ovarian cycle.

Antczak A, Ciebiada M, Kharitonov SA, Gorski P, Barnes PJ.

Inflammation. 2012 Apr;35(2):554-9. doi: 10.1007/s10753-011-9345-1.

12.

Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose.

McWilliams A, Beigi P, Srinidhi A, Lam S, MacAulay CE.

IEEE Trans Biomed Eng. 2015 Aug;62(8):2044-54. doi: 10.1109/TBME.2015.2409092. Epub 2015 Mar 11.

PMID:
25775482
13.

Electronic nose breathprints are independent of acute changes in airway caliber in asthma.

Lazar Z, Fens N, van der Maten J, van der Schee MP, Wagener AH, de Nijs SB, Dijkers E, Sterk PJ.

Sensors (Basel). 2010;10(10):9127-38. doi: 10.3390/s101009127. Epub 2010 Oct 12.

14.

Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.

Finamore P, Pedone C, Scarlata S, Di Paolo A, Grasso S, Santonico M, Pennazza G, Antonelli Incalzi R.

Int J Chron Obstruct Pulmon Dis. 2018 May 1;13:1441-1448. doi: 10.2147/COPD.S159684. eCollection 2018.

15.

Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air.

Meyer N, Dallinga JW, Nuss SJ, Moonen EJ, van Berkel JJ, Akdis C, van Schooten FJ, Menz G.

Respir Res. 2014 Nov 28;15:136. doi: 10.1186/s12931-014-0136-8.

16.

Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study.

de Heer K, van der Schee MP, Zwinderman K, van den Berk IA, Visser CE, van Oers R, Sterk PJ.

J Clin Microbiol. 2013 May;51(5):1490-5. doi: 10.1128/JCM.02838-12. Epub 2013 Mar 6.

17.

Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.

Fens N, Zwinderman AH, van der Schee MP, de Nijs SB, Dijkers E, Roldaan AC, Cheung D, Bel EH, Sterk PJ.

Am J Respir Crit Care Med. 2009 Dec 1;180(11):1076-82. doi: 10.1164/rccm.200906-0939OC. Epub 2009 Aug 27.

PMID:
19713445
18.

Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.

Thekedar B, Oeh U, Szymczak W, Hoeschen C, Paretzke HG.

J Breath Res. 2011 Mar;5(1):016001. doi: 10.1088/1752-7155/5/1/016001. Epub 2010 Dec 23.

PMID:
21383425
19.

Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease.

Sibila O, Garcia-Bellmunt L, Giner J, Merino JL, Suarez-Cuartin G, Torrego A, Solanes I, Castillo D, Valera JL, Cosio BG, Plaza V, Agusti A.

Respir Med. 2014 Nov;108(11):1608-14. doi: 10.1016/j.rmed.2014.09.008. Epub 2014 Sep 19.

20.

Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma.

Brinkman P, van de Pol MA, Gerritsen MG, Bos LD, Dekker T, Smids BS, Sinha A, Majoor CJ, Sneeboer MM, Knobel HH, Vink TJ, de Jongh FH, Lutter R, Sterk PJ, Fens N.

Clin Exp Allergy. 2017 Sep;47(9):1159-1169. doi: 10.1111/cea.12965. Epub 2017 Jul 10.

PMID:
28626990

Supplemental Content

Support Center